Journal
SCIENCE OF THE TOTAL ENVIRONMENT
Volume 663, Issue -, Pages 496-506Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.scitotenv.2019.01.283
Keywords
Pharmaceutical removal; Biofilm; EBPR; PHA
Categories
Funding
- Innovationsfonden Denmark [5190-000318]
Ask authors/readers for more resources
Further biological polishing of micropollutants in WWTP effluents is limited by the lack of available carbon for cometabolic degradation. Metabolism of polyhydroxyalkanoates (PHAs) stored intracellularly during enhanced biological phosphorus removal (EBPR) could serve as carbon source for post-denitrification and micropollutant cometabolism. The removal of nine micropollutants (i.e., pharmaceuticals and corrosion inhibitors) was investigated by using Moving Bed Biofilm Reactors (MBBRs), selecting phosphorus (PAO) or glycogen (GAO) accumulating organisms under different redox conditions. Three laboratory-scale MBBRs were operated in sequencing-batch mode under cyclical anaerobic and aerobic/anoxic conditions for phosphorus removal. Batch experiments were performed to evaluate the biodegradation potential of micropollutants along with the utilization of internally stored PHA. Experiments showed that aerobic PAO were able to efficiently remove most of the targeted micropollutants. The removal of benzotriazole, 5-methyl-1H-benzotriazole, carbamazepine, ketoprofen and diclofenac occurred simultaneously to phosphorus uptake and terminated when phosphorus was no longer available. Denitrifying PAO and aerobic GAO exhibited lower removal of micropollutants than aerobic PAO. Degradation profiles of stored PHA suggested a diverse utilization of the different fractions of PHA for phosphorus and micropollutant removal, with PHV (poly 3-hydroxyvalerate) most likely used for the cometabolism of targeted micropollutants. (C) 2019 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available